SGB-3383

· Suzhou Sanegene Bio Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SGB-3383, covering 2025-06-03 to 2025-06-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGB-3383 in Healthy Subjects [Phase 1]